Lucio Velásquez

Lucio Velásquez

Public Health, Universidad Andina del Cusco, Cusco, Peru
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Respiratory Physiology & Neurobiology
Verified
Journal Article
Closed access
CHCharles Huamaní
Charles Huamaní
Lucio VelásquezLucio Velásquez
Lucio Velásquez
SMSonia Montes
Sonia Montes
Franklin MIRANDA -SOLISFranklin MIRANDA -SOLIS
Franklin MIRANDA -SOLIS

20 September 2021 in PeerJ
Verified
Journal Article
Open access
PDF file
CHCharles Huamaní
Charles Huamaní
Lucio VelásquezLucio Velásquez
Lucio Velásquez
SMSonia Montes
Sonia Montes
AMAna Mayanga-Herrera
Ana Mayanga-Herrera
ABAntonio Bernabé-Ortiz
Antonio Bernabé-Ortiz
Background: There are several ecological studies, but few studies of the prevalence of SARS-COV-2 at high altitude. We aimed to estimate the population-based seroprevalence of SARS-COV-2 in three settings of Cusco at the end of the first wave among adults.Methods: A population-based survey was conducted in September 2020, in three settings in the region of Cusco: (1) Cusco city at 3,300 meters above the sea level (m.a.s.l.), (2) the periphery of Cusco (Santiago, San Jerónimo, San Sebastián, and Wanchaq) at 3,300 m.a.s.l., and (3) Quillabamba city, located at 1,050 m.a.s.l. People aged ≥ 18 years within a family unit were included. The diagnosis of SARS-CoV-2 infection was based on identifying anti- SARS-CoV-2 total antibodies (IgM and IgG) in serum using the Elecsys Anti-SARS-CoV-2 chemiluminescence test.Results: We enrolled 1924 participants from 712 families. Of the total, 637 participants were anti-SARS-CoV-2 seropositive. Seroprevalence was 38.8% (95% CI [33.4%–44.9%]) in Cusco city, 34.9% (95% CI [30.4%–40.1%]) in the periphery of Cusco, and 20.3% (95% CI [16.2%–25.6%]) in Quillabamba. In 141 families (19.8%; 95% CI [17.0%–22.8%]) the whole members were positive to the test. Living with more than three persons in the same house, a positive COVID-19 case at home, and a member who died in the last five months were factors associated with SARS-COV-2 seropositivity. Dysgeusia/dysosmia was the symptom most associated with seropositivity (aPR = 2.74, 95% CI [2.41–3.12]); whereas always wearing a face shield (aPR = 0. 73; 95% CI [0.60–0.89]) or a facial mask (aPR = 0.76, 95% CI [0.63–0. 92) reduced that probability.Conclusions: A great proportion of Cusco’s city inhabitants presented anti-SARS-CoV-2 antibodies at the end of the first wave, with significant differences between settings. Wearing masks and face shields were associated with lower rate of seropositivity; however, efforts must be made to sustain them over time since there is still a high proportion of susceptible people.

Verified
Journal Article
Open access
PDF file
FCFátima Concha-Velasco
Fátima Concha-Velasco
AMAna G. Moncada-Arias
Ana G. Moncada-Arias
MAMaría K. Antich
María K. Antich
CDCarolina J. Delgado-Flores
Carolina J. Delgado-Flores
CRCesar Ramírez-Escobar
Cesar Ramírez-Escobar
SLSteev Loyola
Steev Loyola
Risk factors for COVID-19 death in high-altitude populations have been scarcely described. This study aimed to describe risk factors for COVID-19 death in three referral hospitals located at 3399 m in Cusco, Peru, during the first 14 months of the pandemic. A retrospective multicenter cohort study was conducted. A random sample of ~50% (1225/2674) of adult hospitalized patients who died between 1 March 2020 and 30 June 2021 was identified. Of those, 977 individuals met the definition of death by COVID-19. Demographic characteristics, intensive care unit (ICU) admission, invasive respiratory support (IRS), disease severity, comorbidities, and clinical manifestation at hospital admission were assessed as risk factors using Cox proportional-hazard models. In multivariable models adjusted by age, sex, and pandemic periods, critical disease (vs. moderate) was associated with a greater risk of death (aHR: 1.27; 95%CI: 1.14–1.142), whereas ICU admission (aHR: 0.39; 95%CI: 0.27–0.56), IRS (aHR: 0.37; 95%CI: 0.26–0.54), the ratio of oxygen saturation (ROX) index ≥ 5.3 (aHR: 0.87; 95%CI: 0.80–0.94), and the ratio of SatO2/FiO2 ≥ 122.6 (aHR: 0.96; 95%CI: 0.93–0.98) were associated with a lower risk of death. The risk factors described here may be useful in assisting decision making and resource allocation.

20 January 2021 in medRxiv
Verified
Preprint
Open access
PDF file
CHCharles Huamaní
Charles Huamaní
Lucio VelásquezLucio Velásquez
Lucio Velásquez
SMSonia Montes
Sonia Montes
AMAna Mayanga-Herrera
Ana Mayanga-Herrera
ABAntonio Bernabe-Ortiz
Antonio Bernabe-Ortiz
Background Little evidence exists about the prevalence of COVID-19 infection at high altitude. We aimed to estimate the population-based seroprevalence of COVID-19 in Cusco at the end of the first wave. Methods A population-based survey was conducted in September 2020 in three settings in Cusco: (1) Cusco city at 3300 meters above the sea level (m.a.s.l.), (2) the periphery of Cusco (Santiago, San Jerónimo, San Sebastián, and Wanchaq) at 3300 m.a.s.l., and (3) Quillabamba city, located at 1050 m.a.s.l. People aged ≥18 years within a family unit were included. The diagnosis of COVID-19 infection was based on identifying total antibodies (IgM and IgG) anti-SARS-CoV-2 in serum using the Elecsys Anti-SARS-CoV-2 chemiluminescence test. Findings We enrolled 1924 participants from 712 families. Of the total, 637 participants were COVID-19 seropositive. Seroprevalence was 38·8% (95%CI: 33·4%-44·9%) in Cusco city, 34·9% (95%CI: 30·4%-40·1%) in the periphery of Cusco, and 20·3% (95%CI: 16·2%-25·6%) in Quillabamba. In 141 families (19·8%; 95%CI: 17·0%-22·8%) the whole members were positive to the test. Living with more than three persons in the same house, a positive COVID-19 case at home, and a member who died in the last five months were factors associated with COVID-19 positivity. The smell/taste alteration was the symptom most associated with seropositivity (aOR= 14·27, 95% CI: 8·24-24·70); whereas always wearing a face shield (aOR= 0·62; 95% CI: 0·46-0·84) or a facial mask (aOR= 0·65, 95% CI: 0·47-0·88) reduced that probability. Interpretation Seroprevalence of COVID-19 in Cusco was high, with significant differences between settings. Wearing masks and face shields were associated with lower rate of infection; however, efforts must be made to sustain them over time since there is still a high proportion of susceptible people. Funding Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica (FONDECYT – Perú) and Universidad Andina del Cusco.

1 January 2021 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
CHCharles Huamani
Charles Huamani
Lucio VelásquezLucio Velásquez
Lucio Velásquez
SMSonia Montes
Sonia Montes
AMAna Mayanga-Herrera
Ana Mayanga-Herrera
ABAntonio Bernabé-Ortiz
Antonio Bernabé-Ortiz
Background: Little evidence exists about the prevalence of COVID-19 infection at high altitude. We aimed to estimate the population-based seroprevalence of COVID-19 in Cusco at the end of the first wave. Methods: A population-based survey was conducted in September 2020 in three settings in Cusco: (1) Cusco city at 3300 meters above the sea level (m.a.s.l.), (2) the periphery of Cusco (Santiago, San Jerónimo, San Sebastián, and Wanchaq) at 3300 m.a.s.l., and (3) Quillabamba city, located at 1050 m.a.s.l. People aged ≥18 years within a family unit were included. The diagnosis of COVID-19 infection was based on identifying total antibodies (IgM and IgG) anti- SARS-CoV-2 in serum using the Elecsys Anti-SARS-CoV-2 chemiluminescence test. Findings: We enrolled 1924 participants from 712 families. Of the total, 637 participants were COVID-19 seropositive. Seroprevalence was 38·8% (95%CI: 33·4%-44·9%) in Cusco city, 34·9% (95%CI: 30·4%-40·1%) in the periphery of Cusco, and 20·3% (95%CI: 16·2%-25·6%) in Quillabamba. In 141 families (19·8%; 95%CI: 17·0%-22·8%) the whole members were positive to the test. Living with more than three persons in the same house, a positive COVID-19 case at home, and a member who died in the last five months were factors associated with COVID-19 positivity. The smell/taste alteration was the symptom most associated with seropositivity (aOR= 14·27, 95% CI: 8·24-24·70); whereas always wearing a face shield (aOR= 0·62; 95% CI: 0·46- 0·84) or a facial mask (aOR= 0·65, 95% CI: 0·47-0·88) reduced that probability. Interpretation: Seroprevalence of COVID-19 in Cusco was high, with significant differences between settings. Wearing masks and face shields were associated with lower rate of infection; however, efforts must be made to sustain them over time since there is still a high proportion of susceptible people. Funding Statement: Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica (FONDECYT – Perú) and Universidad Andina del Cusco. Declaration of Interests: Authors declare no competing interests. Ethics Approval Statement: The study was approved by the Ethics Committee of the Universidad Científica del Sur (code 051-2020-PRO99).